April 2024 Test Bulletin

April 5, 2024

We have introduced new tests such as the Encephalitis Antibody Panel and the Comprehensive Chronic Urticaria Panel, while discontinuing certain offerings like the Fetal Fibronectin test, directing clinicians to local hospital resources instead. Additionally, updates include the transition of molecular testing for STIs to new platforms and the discontinuation of the JAK2 V617F Cascading Reflex test, replaced by a more comprehensive myeloproliferative neoplasms diagnostic panel.